Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Tempus AI, Inc. (NASDAQ:TEM) have been given an average rating of “Moderate Buy” by the ten ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among brokers that have covered the stock in the last year is $54.22.

A number of brokerages have issued reports on TEM. Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and lifted their target price for the company from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Piper Sandler reissued a “neutral” rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Loop Capital raised their price target on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. Finally, Stifel Nicolaus downgraded Tempus AI from a “buy” rating to a “hold” rating and increased their price objective for the stock from $45.00 to $65.00 in a report on Monday, November 11th.

Tempus AI Stock Performance

TEM opened at $53.16 on Friday. The firm has a fifty day simple moving average of $53.61. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI has a 12-month low of $22.89 and a 12-month high of $79.49.

Hedge Funds Weigh In On Tempus AI

A number of hedge funds have recently made changes to their positions in TEM. Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Tempus AI by 1,591.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after buying an additional 1,145,698 shares during the period. Sigma Planning Corp acquired a new position in Tempus AI during the third quarter worth $1,323,000. Dakota Wealth Management bought a new position in shares of Tempus AI during the third quarter valued at $1,185,000. Davidson Kempner Capital Management LP acquired a new stake in shares of Tempus AI in the 2nd quarter valued at $2,271,000. Finally, NEA Management Company LLC grew its holdings in shares of Tempus AI by 17.8% in the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after purchasing an additional 813,169 shares during the last quarter.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.